Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine in Preterm Neonates with RDS
NCT07437391Recruiting
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of levocarnitine in respiratory distress syndrome (RDS) (2 arms). Primary endpoints: Mortality at 30 days and Change in Weight at 30 days. Started Jan 2026; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT07437391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07437391.